Related Experiment Video

Updated: May 7, 2026

Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancers

Thomas E Kruger1, Andrew H Miller1, Andrew K Godwin2

  • 1Harrington Laboratory for Molecular Orthopedics, Department of Orthopedic Surgery, University of Kansas Medical Center, Kansas City, KS 66160, USA.

Insights

Bone sialoprotein (BSP) and osteopontin (OPN) promote cancer metastasis to bone. Understanding these small integrin-binding ligand N-linked glycoproteins (SIBLINGs) aids in developing new cancer diagnostics and therapies.

Area of Science:

  • Oncology
  • Biochemistry
  • Cell Biology

Background:

  • Malignant cell metastasis to bone is a complex process.
  • Small integrin-binding ligand N-linked glycoproteins (SIBLINGs), including bone sialoprotein (BSP) and osteopontin (OPN), are implicated in cancer progression.
  • Elevated BSP and OPN expression is observed in cancers that preferentially metastasize to the skeleton.

Purpose of the Study:

  • To elucidate the role of BSP and OPN in tumor progression and metastasis to bone.
  • To understand how malignant cells mimic skeletal cells ('osteomimicry').
  • To explore the contribution of BSP and OPN to the bone microenvironment's altered pathophysiology.

Main Methods:

  • Analysis of gene expression profiles in osteotropic cancers.
  • Investigation of BSP and OPN interactions with transmembrane receptors.
  • Studies on the 'osteomimicry' phenomenon in malignant cells.

Main Results:

  • BSP and OPN exhibit pro-metastatic activities, including promoting proliferation, detachment, and invasion.
  • Increased expression of BSP and OPN correlates with skeletal metastasis in various human cancers.
  • Malignant cells adopt skeletal lineage gene expression patterns, facilitated by BSP and OPN.

Conclusions:

  • BSP and OPN play critical roles in promoting tumor metastasis to bone.
  • Understanding the osteomimicry mechanism driven by BSP and OPN is key to targeting skeletal metastases.
  • Further research into BSP and OPN functions can lead to improved diagnostic and therapeutic strategies for bone-metastatic cancers.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Bone Cells and Tissue01:30

Bone Cells and Tissue

Bones contain a relatively small number of cells entrenched in a matrix of organic and inorganic components. Although bone cells compose only a small amount of the bone volume, they are crucial to its function. Four types of cells are found within the bone tissue— osteoblasts, osteocytes, osteogenic cells, and osteoclasts.
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the periosteum and...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...